| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/BMJ.320.7250.1647 |
| P8608 | Fatcat ID | release_yciuiiclibfgfhbmru6mrwclfq |
| P3181 | OpenCitations bibliographic resource ID | 1731715 |
| P932 | PMC publication ID | 1127427 |
| P698 | PubMed publication ID | 10856069 |
| P2093 | author name string | A Deacon | |
| T Peters | |||
| H Thadani | |||
| P2860 | cites work | Successful treatment of seizures and porphyria with gabapentin | Q72650009 |
| Acute intermittent porphyria with seizures. Anticonvulsant medication-induced metabolic changes | Q72825164 | ||
| Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria | Q72840955 | ||
| Advances in understanding and treating 'the little imitator,' acute porphyria | Q72840988 | ||
| The acute porphyrias | Q73396144 | ||
| Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload | Q74027228 | ||
| Porphyria cutanea tarda | Q74359781 | ||
| Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria | Q24559969 | ||
| Early administration of heme arginate for acute porphyric attacks | Q34061438 | ||
| Seizure management in acute hepatic porphyria: risks of valproate and clonazepam | Q34268927 | ||
| Laboratory investigation of the porphyrias | Q34640627 | ||
| Erythropoietic protoporphyria. | Q34723332 | ||
| Smoking and recurrent attacks of acute intermittent porphyria | Q35179089 | ||
| Porphyrias, porphyrins and hepatocellular cancer | Q36027827 | ||
| Free radicals involvement in neurological porphyrias and lead poisoning | Q37198161 | ||
| Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment | Q38607216 | ||
| Identification of acute porphyria: evaluation of a commercial screening test for urinary porphobilinogen | Q39226230 | ||
| Porphyrias: animal models and prospects for cellular and gene therapy. | Q40433965 | ||
| Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases | Q40725464 | ||
| Congenital erythropoietic porphyria | Q41417569 | ||
| Acute porphyrias: pathogenesis of neurological manifestations | Q41727540 | ||
| Low-dose oral chloroquine in the treatment of porphyria cutanea tarda | Q41918263 | ||
| Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: Potential implications for patients with acute porphyria | Q42548709 | ||
| Pregnancy and the acute porphyrias | Q44000303 | ||
| Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria | Q57083724 | ||
| Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma | Q61890887 | ||
| Grand mal seizures and acute intermittent porphyria. The problem of differential diagnosis and treatment | Q67514756 | ||
| Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases | Q68075802 | ||
| A plasma porphyrin fluorescence marker for variegate porphyria | Q71204636 | ||
| Is the Watson-Schwartz screening method for porphobilinogen reliable? | Q71808299 | ||
| Gabapentin treatment of seizures in acute intermittent porphyria | Q72319676 | ||
| P433 | issue | 7250 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | porphyria | Q271759 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 1647-51 | |
| P577 | publication date | 2000-06-17 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Diagnosis and management of porphyria | |
| P478 | volume | 320 |
| Q43010126 | A retrospective analysis of outcome of pregnancy in patients with acute porphyria |
| Q41508088 | Acute Intermittent Porphyria: A Diagnostic Challenge |
| Q34630943 | Acute intermittent porphyria and systemic lupus erythematosus: report of a case and review of the literature |
| Q36142293 | Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome and lateralized periodic discharges plus fast activity on EEG. |
| Q48761488 | Acute intermittent porphyria: a diagnostic challenge |
| Q95785553 | Anaesthesia is also risky in patients with porphyria |
| Q50948081 | Anxiety and depression in the acute porphyrias |
| Q35586929 | CYP2D6 polymorphisms in patients with porphyrias |
| Q38164825 | Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology |
| Q83655878 | Diagnosis of the mutation responsible for acute intermittent porphyria in a newborn |
| Q42687877 | Electrospray ionization on porous spraying tips for direct sample analysis by mass spectrometry: enhanced detection sensitivity and selectivity using hydrophobic/hydrophilic materials as spraying tips |
| Q43088814 | Erythrocyte protoporphyrin fluorescence as a potential marker of diabetes |
| Q42053995 | Feigning acute intermittent porphyria |
| Q46756265 | Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries |
| Q44555371 | International air travel: a risk factor for attacks in acute intermittent porphyria |
| Q57991899 | Levetiracetam in Idiopathic Generalised Epilepsy and Porphyria??Cutanea Tarda |
| Q35539189 | Mass-spectrometric profiling of porphyrins in complex biological samples with fundamental, toxicological, and pharmacological applications |
| Q36476241 | Methotrexate and actinomycin D chemotherapy in a patient with porphyria: a case report |
| Q42478276 | Mitochondrial energetic defects in muscle and brain of a Hmbs-/- mouse model of acute intermittent porphyria |
| Q28834645 | N-alkylprotoporphyrin formation and hepatic porphyria in dogs after administration of a new antiepileptic drug candidate: mechanism and species specificity |
| Q35486409 | Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases |
| Q43543002 | Novel splicing mutation of the PPOX gene (IVS10 + 1G-->A) detected by denaturing high-performance liquid chromatography. |
| Q92206170 | Porphyria and dementia: a case report |
| Q34730019 | Propofol and sevoflurane induce distinct burst suppression patterns in rats |
| Q40679598 | Regional Variation in Analytical Techniques used in the Diagnosis and Monitoring of Porphyria: a Case for Harmonisation? |
| Q32026567 | Review article: the potential role for photodynamic therapy in the management of upper gastrointestinal disease. |
| Q35833280 | Schizoaffective Disorder With Missed Diagnosis of Acute Porphyria: A Case Report and Overview |
| Q51057058 | Self-rated psychosocial consequences and quality of life in the acute porphyrias |
| Q46944865 | Suxamethonium in the intensive care unit: "Fool me once, shame on you; fool me twice, shame on me". |
| Q37500044 | The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine. |
| Q37332025 | Variegate porphyria complicated by systemic AA amyloidosis: a case report. |
| Q51961553 | Vomiting, burns, and irrational behaviour |
Search more.